Medpace, Fortrea Cut as Jefferies Reviews CROs Amid Biotech Headwinds
IQVIA Holdings Inc. (IQV): Hedge Funds Are Bullish On This Trending AI Stock Right Now
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating
Truist Financial analyst Jailendra Singh maintains $IQVIA Holdings(IQV.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 35.6% and a total average return of -14.5%
Truist Financial Gives a Buy Rating to IQVIA Holdings (IQV)
Overweight Quality Stocks With Positive EPS Revision - MS
Is Now The Time To Put IQVIA Holdings (NYSE:IQV) On Your Watchlist?
Sword of Justice! The US FTC sues three major pharmaceutical "middlemen", vows to correct the distorted profit chain.
The USA's FTC announced on its official website that it has filed a lawsuit against three major "pharmacy benefit managers" and their affiliated organizations, accusing them of engaging in anti-competitive and unfair kickback practices. FTC also "clearly stated" in the declaration its deep concern about the roles played by eli lilly and co, novo-nordisk a/s, sanofi, and other insulin pharmaceutical companies, and the competition bureau may recommend prosecuting these pharmaceutical companies in future enforcement actions.
A Closer Look at 13 Analyst Recommendations For IQVIA Hldgs
IQVIA Holdings Is Maintained at Neutral by Baird
Baird Maintains IQVIA Holdings(IQV.US) With Hold Rating, Raises Target Price to $256
Baird analyst Eric Coldwell maintains $IQVIA Holdings(IQV.US)$ with a hold rating, and adjusts the target price from $251 to $256.According to TipRanks data, the analyst has a success rate of 54.2%
Express News | IQVIA Holdings Inc : Baird Raises Target Price to $256 From $251
ICON Draws Bullish View at Leerink on Business Model
IQVIA Holdings' (NYSE:IQV) Investors Will Be Pleased With Their Decent 52% Return Over the Last Five Years
J&J Leads H1 Healthcare Deals as Big Pharma Dealmaking Returns: Report
Goldman Thinks IQVIA Holdings Inc. (IQV) Is A Long-Term AI Stock Set To Rally Eventually
Is IQVIA Holdings Stock Underperforming the S&P 500?
Supernus Cut to Neutral at Piper Sandler on Qelbree Growth Trajectory
IQVIA Applauded by Frost & Sullivan for Improving the Performance of QARA Professionals, Patient Safety, and Commercial Performance With Its AI Solutions
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 38% Undervaluation?